Uniphar plc UPR.IR · Stock Open Uniphar plc in new tab
Uniphar plc Analysis (UPR.IR)
Is Uniphar plc a good investment? Uniphar plc (UPR.IR) is currently trading at 3.98 EUR. Market analysts have a consensus price target of 5.57 EUR. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 18.71. This valuation is generally in line with the broader market.
Earnings Schedule: Uniphar plc is expected to release its next earnings report on March 2, 2027. The market consensus estimate for Forward EPS is 0.28.
For income investors, Uniphar plc pays a dividend yield of 0.18%. With a payout ratio of 10%, the dividend appears sustainable.
Investor FAQ
Does Uniphar plc pay a dividend?
Yes, it pays an annual dividend of 0.01 EUR (0.18% yield).
What asset class is Uniphar plc?
Uniphar plc is classified as a Stock. You can compare it against 3 other assets in the "Related Symbols" list on this page.
When is the next earnings date?
The next earnings date is projected to be March 2, 2027. The company currently has a trailing EPS of 0.21.
Company Profile
Uniphar plc, together with its subsidiaries, operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, the Netherlands, and internationally. It operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. The company provides sales, marketing, servicing, quality, compliance, regulatory support, and distribution services to medical device manufacturers; high-value services across the life cycle of a pharmaceutical product; and healthcare professionals with access to medicines that cannot source through traditional channels. It is also involved in the pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals and veterinary surgeons; operates a network of pharmacies under the Life, Allcare, Hickey's, and McCauley brands. In addition, the company provides pharmacy support, pharmaceutical supply chain and services, medical device distribution, specialist nursing and infusion, outsourcing and resourcing, healthcare technology, medical affairs, online pharmacy and product fostering, pharmaceutical wholesale distributor, retail pharmacy software and technology, and telecommunications support services, as well as specialist provider of pharmaceuticals. Uniphar plc was founded in 1967 and is headquartered in Dublin, Ireland.
| Year | Total Dividends |
|---|---|
| ▸2026 |
0.01 EUR
|
| Oct. 9, 2026 | 0.0131 |
| ▸2025 |
0.02 EUR
|
| Oct. 3, 2025 | 0.0071 |
| May 16, 2025 | 0.0125 |
| ▸2024 |
0.02 EUR
|
| Sept. 12, 2024 | 0.0067 |
| April 18, 2024 | 0.0119 |
| ▸2023 |
0.02 EUR
|
| Sept. 28, 2023 | 0.0064 |
| April 20, 2023 | 0.0110 |
| ▸2022 |
0.02 EUR
|
| Sept. 8, 2022 | 0.0061 |
| April 21, 2022 | 0.0110 |
| ▸2021 |
0.02 EUR
|
| Oct. 11, 2021 | 0.0056 |
| May 17, 2021 | 0.0150 |
| ▸2020 |
0.01 EUR
|
| April 30, 2020 | 0.0073 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Uniphar plc | Oct 09, 2026 | Upcoming | 0.0131 EUR |
Community Discussion